Dr. Mark Bounthavong, Pharm.D., Ph.D.
Associate Professor of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
Dr. Bounthavong’s research interests include pharmacoeconomics, program and implementation evaluations, applied econometrics, and evidence-synthesis using Bayesian methods. More recently, Dr. Bounthavong’s research has centered around evaluating academic detailing’s impact on aligning provider’s behavior with evidence-based practice, particularly with the opioid epidemic.
Education: B.S. in Biological Sciences (1999) University of California, Irvine; PharmD (2004) Western University of Health Sciences College of Pharmacy; PGY1 Pharmacy Practice Residency (2005) VA Loma Linda Medical Center; Pharmacoeconomics and Outcomes Research Fellowship (2007) Western University of Health Sciences College of Pharmacy; Master of Public Health (2013) Emory University Rollins School of Public Health; PhD (2018) University of Washington, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute.
Awards and Honors: Best Paper Award (2018) Vancouver Health Economics Methodology Meeting, Vancouver, Canada; U.S. Under Secretary of Health Pharmacy Practice Innovation Award (2009, 2017), U.S. Department of Veterans Affairs; American Society of Health-System Pharmacists Best Practice Award (2009, 2017); Alumni Achievement Award (2016) 20th Anniversary Gala Celebration. College of Pharmacy, Western University of Health Sciences; AHRQ T32 Fellowship (2013-2015) Agency for Healthcare Research and Quality T32 PhD Student training grant#T32HS013853; American Society of Health-System Pharmacists Literature (Best Paper) Award (2010); Distinguish Service Award (2009) Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific.
Leadership Experience: Associate Editor (2020-present), Substance Abuse journal (SAj) Print ISSN: 0889-7077; Online ISSN: 1547-0164; Editorial Advisory Board Member (2021-present), Journal of the American Pharmacist Association. Print ISSN: 1544-3191; Online ISSN: 1544-3450; Chair (2019-present), Pharmacy Evaluation-Research Selection Committee, VA Pharmacy Benefits Management Academic Detailing Service; Chair (2021-present) and Steering Committee Member (2018-present), New Professions Steering Committee, International Society for Pharmacoeconomics and Outcomes Research; Director, PGY1 Managed Care Pharmacy Residency (2008-2013) Veterans Affairs San Diego Healthcare System.
- Chair, SPPS 209 – Applied Pharmacoeconomics SPPS 209
- Co-chair, SPPS 206 – Study Design and Biostatistics I
- Co-chair, SPPS 208 – Study Design and Biostatistics II
- Published data used by the U.S. Office of the Inspector General’s Report on the opioid crisis
- Implemented and maintained the first pharmacist-run immunization clinic at the Veterans Health Administration
- Developed national formulary monographs for VA Pharmacy Benefits Management
- Contributed (economic analysis) to the establishment of the first emergency department pharmacist position at the Veterans Health Administration
- Bounthavong M, Lau MK, Kay CL, et al. (2021). Impact of Implementing an Academic Detailing Program on Opioid-Benzodiazepine Co-Prescribing Trends at the U.S. Department of Veterans Affairs. Pain Med 22(6):1426-1434.
- Bounthavong M, Lau MK, Popish SJ, et al. (2020). Impact of academic detailing on benzodiazepine use among veterans with posttraumatic stress disorder. Subst Abus. 41(1):101-109.
- Bounthavong M. et al. (2019) Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration. Health Serv Res. 54(5):1055-1064.
- Bounthavong M, Butler J, Dolan CM, et al. (2018). Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia. Pharmacoeconomics. 36(12):1463-1473.
- Bounthavong M, Harvey MA, Wells DL, et al. (2017. Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis. J Am Pharm Assoc 57(2S):S68-S72.
- Aldridge VE, Park HK, Bounthavong M, Morreale AP. (2009) Implementing a comprehensive, 24-hour emergency department pharmacy program. Am J Health Syst Pharm. 66(21):1943-1947.